Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy [Phase 3]
A Phase 3 trial at Oslo University Hospital is evaluating dual therapy with a CGRP monoclonal antibody plus OnabotulinumtoxinA versus CGRP m…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack [Phase 4]
Phase 4 clinical trial comparing analgesic effects of intravenous ibuprofen and tenoxicam for acute migraine; the study is currently active …
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Prevalence and Determinants of Migraine Among Headache Patients
This ClinicalTrials.gov entry describes a study on the prevalence and determinants of migraine among patients with headache, sponsored by Un…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experiences [NA]
A clinical trial evaluating whether online mindfulness therapy reduces pain and stress in adults with chronic migraine and a history of adve…
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for amitriptyline hydrochloride by Advagen Pharma Ltd, indicating an approved change to an alrea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine [NA]
An ongoing clinical trial is evaluating peripheral cryoneurolysis in adults with chronic migraine.
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, authorizing a generic product's appro…
-
FDA label_change · 2025-06-19FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for AIMOVIG (erenumab-aooe) from Amgen, resulting in changes to the product labeling.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
A recruiting clinical trial (MI-DEAR) studies whether fremanezumab for migraine with depressive symptoms reduces caregiver burden and improv…
-
CLINICAL_TRIALS other · 2025-06-17Clinical Trial Update: Effectiveness of Auricular Acupuncture for Migraine [NA]
Clinical trial update describing a study on auricular acupuncture for migraine; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: The Efficacy and Safety of Acupuncture for Prophylaxis of Menstrually Related Migraine [NA]
A clinical trial update describing a study on the efficacy and safety of electroacupuncture for prophylaxis of menstrually related migraine;…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Carotid Sinus Massage in Trendelenburg Position for Headache Relief [NA]
A clinical trial evaluating carotid sinus massage in Trendelenburg position for relief of migraine and tension-type headache is currently re…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals [Phase 4]
Phase 4 clinical trial evaluating whether oral caffeine intake influences the severity of acute migraine attacks, assessed by Visual Analog …
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED [Phase 1]
A Phase 1 randomized controlled trial evaluated intravenous dexamethasone to prevent relapse of migraine in children presenting to the emerg…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Educational Video Program to Promote Physical Activity and Reduce Migraine Frequency in Adults With Migraine [NA]
A completed clinical trial evaluating an educational video program to promote physical activity and reduce migraine frequency in adults with…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Neuro-Complex & Multi Supplements for Migraine Prevention [NA]
A clinical trial evaluating Neuro-Complex and multi-supplements for migraine prevention is currently recruiting. The sponsor is Benfida, a d…
-
FDA approval · 2025-06-10FDA Approved: QULIPTA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for QULIPTA (atogepant) submitted by AbbVie Inc.
-
FDA approval · 2025-06-05FDA Approved: UBRELVY — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for UBRELVY (ubrogepant) by Allergan, Inc.
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Substance P-Induced Migraine Attacks Without Aura [NA]
A clinical trial from the Danish Headache Center is assessing substance P–induced migraine attacks without aura. The study is currently recr…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches
The non-interventional pilot trial investigating the role of gut flora in migraine headaches has been withdrawn. No results were reported an…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Effects of Progressive Muscle Relaxation Training Applied in Addition to Aerobic Exercise Training in Individuals With Migraine Diagnosis [NA]
This clinical trial protocol investigates whether adding progressive muscle relaxation training to aerobic exercise improves outcomes for pe…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache [NA]
Completed clinical trial of a non-invasive neuromodulation device for episodic migraine with results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine [NA]
This clinical trial update notes completion of a study evaluating greater occipital nerve blockade and sphenopalatine ganglion blockade in p…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial [Phase 2]
This is a Phase 2 clinical trial in adolescents evaluating cannabis for chronic migraine, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: The Effect of Cervical Stabilization Training in Individuals With Migraine [NA]
This clinical trial evaluated the effect of cervical stabilization training in individuals with migraine. It has completed.